Company attributes
Industry
Location
Founded Date
2013
Competitors
Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Active
DNA Capital is a Brazil based venture capital firm founded by Mario Sergio Ribeiro in 2013. The firm prefers to invests in companies that focuses on the healthcare sector. This firm invests in early stage ventures, last stage ventures, and seed ventures in series A and series B rounds.
As of December 2019, DNA Capital is actively looking for new investment opportunities. The firm's notable investment portfolio includes Alto Pharmacy, Arterys, Beep Saúde, Cambridge Epigenetix, Clover Health, CM Tecnologia, Feegow Clinic, OMNY, The CareVoice and uBiome.
Timeline
No Timeline data yet.
Associated Investment Funds
Accelerator Batches
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.